therapies.U.K. researcher Dr. Deborah Malden said the results of the new study should be approached with caution and that more extensive investigations would be needed with larger study groups.“We should be cautious about emphasizing the results with the 93 participants’ results here,” she said. “We would know much more after repeating this study in a large-scale cohort, potentially tens of thousands of individuals, and perhaps a genetic MR (Mendelian randomization) study.”Even so, if the initial study findings are confirmed in large-scale testing, the research team hopes the results could pave the way for population-wide dementia risk categorization and perhaps future development of therapeutic strategies to reduce ADMA levels and/or slow.
Read more on psychcentral.com